UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 397

Sortiert nach

The quality of life in Parkinson's disease

Movement disorders, 2000-03, Vol.15 (2), p.216-223

2000

Volltextzugriff (PDF)

Early treatment of Parkinson's Disease with cabergoline delays the onset of motor complications: Results of a double-blind levodopa controlled trial

Drugs (Basel), 1998, Vol.55, p.23-30

1998

Volltextzugriff (PDF)

Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuations

Journal of neurology, neurosurgery and psychiatry, 1996-01, Vol.60 (1), p.36-40

1996

Volltextzugriff (PDF)

Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts

Journal of the neurological sciences, 1997-10, Vol.151 (1), p.83-87

1997

Volltextzugriff (PDF)

Environmental risk factors in Parkinson's disease

Movement disorders, 1999-11, Vol.14 (6), p.928-939

1999

Volltextzugriff (PDF)

A double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson's disease

Clinical neuropharmacology, 1996-08, Vol.19 (4), p.283-296

1996

Volltextzugriff (PDF)

Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysis

Neurology, 1998-09, Vol.51 (3), p.825

1998

Volltextzugriff (PDF)

PET study on striatal dopamine D2 receptor changes during the progression of early parkinson's disease

Movement disorders, 1993, Vol.8 (2), p.134-138

1993

Volltextzugriff (PDF)

Changing epidemiology of Parkinson's disease in southwestern Finland

Neurology, 1999-01, Vol.52 (2), p.302

1999

Volltextzugriff (PDF)

Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [ 11C]raclopride

Journal of the neurological sciences, 1995-10, Vol.132 (2), p.156-161

1995

Volltextzugriff (PDF)

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up

Neurology, 1987-05, Vol.37 (5), p.826

Rinne, U K

1987

Volltextzugriff (PDF)

Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

Annals of neurology, 1989-07, Vol.26 (1), p.47-50

1989

Volltextzugriff (PDF)

Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia

Acta neurologica Scandinavica, 1995-03, Vol.91 (3), p.159-164

1995

Volltextzugriff (PDF)

Lisuride, a dopamine agonist in the treatment of early Parkinson's disease

Neurology, 1989-03, Vol.39 (3), p.336

Rinne, U K

1989

Volltextzugriff (PDF)

Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease

Movement disorders, 1990, Vol.5 (1), p.55-59

1990

Volltextzugriff (PDF)

Effect of one month's treatment with peripherally acting catechol-O-methyltransferase inhibitor, entacapone, on pharmacokinetics and motor response to levodopa in advanced Parkinsonian patients

Clinical neuropharmacology, 1996-06, Vol.19 (3), p.222-233

1996

Volltextzugriff (PDF)

COMT inhibition in the treatment of Parkinson's disease

Journal of neurology, 1998-11, Vol.245 (11 Suppl 3), p.P25-P34

1998

Volltextzugriff (PDF)

Oxygen toxicity protecting enzymes in Parkinson's disease: Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus

Journal of the neurological sciences, 1988-09, Vol.86 (2), p.321-331

1988

Volltextzugriff (PDF)

Familial occurrence of Parkinson's disease in a community-based case-control study

Parkinsonism & related disorders, 2001-10, Vol.7 (4), p.297-303

2001

Volltextzugriff (PDF)

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease

Journal of neuroscience research, 1990-12, Vol.27 (4), p.494-499

1990

Volltextzugriff (PDF)

PET studies on brain monoamine transporters with carbon-11-β-CIT in Parkinson's disease

The Journal of nuclear medicine (1978), 1995-07, Vol.36 (7), p.1263-1267

1995

Volltextzugriff (PDF)

Validity of clinical diagnosis in dementia: a prospective clinicopathological study

Journal of neurology, neurosurgery and psychiatry, 1985-11, Vol.48 (11), p.1085-1090

1985

Volltextzugriff (PDF)

Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET

Journal of neurology, 2000-04, Vol.247 Suppl 2 (S2), p.II110-113

2000

Volltextzugriff (PDF)

Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls

Neuropathology and applied neurobiology, 1995-02, Vol.21 (1), p.10-17

1995

Volltextzugriff (PDF)

Parkinson's disease in a nationwide twin cohort

Neurology, 1988-08, Vol.38 (8), p.1217

1988

Volltextzugriff (PDF)

1 – 25 von 397

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(329)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Acta Neurologica Scandinavica
(77)
Neurology
(23)
Acta Neurologica Scandinavica. Supplementum
(20)
European Neurology
(20)
Journal Of Neural Transmission
(15)
Journal Of The Neurological Sciences
(15)
Movement Disorders
(14)
Advances In Neurology
(13)
Brain Research
(10)
Duodecim
(10)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The quality of life in Parkinson's disease

Early treatment of Parkinson's Disease with cabergoline delays the onset of motor complications: Results of a double-blind levodopa controlled trial

Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuations

Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts

Environmental risk factors in Parkinson's disease

A double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson's disease

Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysis

PET study on striatal dopamine D2 receptor changes during the progression of early parkinson's disease

Changing epidemiology of Parkinson's disease in southwestern Finland

Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [ 11C]raclopride

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up

Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia

Lisuride, a dopamine agonist in the treatment of early Parkinson's disease

Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease

Effect of one month's treatment with peripherally acting catechol-O-methyltransferase inhibitor, entacapone, on pharmacokinetics and motor response to levodopa in advanced Parkinsonian patients

COMT inhibition in the treatment of Parkinson's disease

Oxygen toxicity protecting enzymes in Parkinson's disease: Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus

Familial occurrence of Parkinson's disease in a community-based case-control study

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease

PET studies on brain monoamine transporters with carbon-11-β-CIT in Parkinson's disease

Validity of clinical diagnosis in dementia: a prospective clinicopathological study

Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [18F]6-fluorodopa PET

Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls

Parkinson's disease in a nationwide twin cohort

Suchergebnisse filtern